Literature DB >> 20458524

oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.

Jingyi Ren1, Wenying Jin, Hong Chen.   

Abstract

CD36, belongs to class B scavenger receptor family, is a macrophage receptor for oxidized low-density lipoprotein (oxLDL) and has been proven to play a critical role in atherosclerotic foam cell formation. In addition, CD36 expression is regulated by many factors including oxLDL and HDL. A recent study suggests that CD36 can also bind with oxidized high-density lipoprotein (oxHDL). However, the direct role of oxHDL in atherosclerosis is still not clear and it is not known whether oxHDL has any influence on the expression of CD36 in macrophages. Here, we performed experiments to investigate the effect of oxHDL on the expression of CD36 on human peripheral blood monocytes-macrophages and the possible mechanisms. Our results suggest that the uptake of oxHDL by CD36 on macrophages accelerates foam cell formation. In addition, oxHDL can down-regulate both the mRNA and surface protein expression of CD36 on human peripheral macrophages in vitro. oxHDL increased the mRNA expression and protein phosphorylation of peroxisome proliferators-activated receptor-gamma (PPARgamma). Using different mitogen-activated protein kinase (MAPK) inhibitors, we demonstrated that oxHDL regulated CD36 and PPARgamma expression in a p38-MAP kinase dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458524     DOI: 10.1007/s11010-010-0481-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

Review 1.  High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences.

Authors:  G A Francis
Journal:  Biochim Biophys Acta       Date:  2000-01-17

Review 2.  Structural modifications of HDL and functional consequences.

Authors:  Gianna Ferretti; Tiziana Bacchetti; Anne Nègre-Salvayre; Robert Salvayre; Nicole Dousset; Giovanna Curatola
Journal:  Atherosclerosis       Date:  2005-09-12       Impact factor: 5.162

Review 3.  Multiple actions of high-density lipoprotein.

Authors:  Matilda Florentin; Evangelos N Liberopoulos; Anthony S Wierzbicki; Dimitri P Mikhailidis
Journal:  Curr Opin Cardiol       Date:  2008-07       Impact factor: 2.161

4.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

Authors:  S Nozaki; H Kashiwagi; S Yamashita; T Nakagawa; B Kostner; Y Tomiyama; A Nakata; M Ishigami; J Miyagawa; K Kameda-Takemura
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 6.  Chemokines in the pathogenesis of vascular disease.

Authors:  Israel F Charo; Mark B Taubman
Journal:  Circ Res       Date:  2004-10-29       Impact factor: 17.367

7.  Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36.

Authors:  Jihong Han; Xiaoye Zhou; Toru Yokoyama; David P Hajjar; Antonio M Gotto; Andrew C Nicholson
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

8.  Mild oxidation promotes and advanced oxidation impairs remodeling of human high-density lipoprotein in vitro.

Authors:  Xuan Gao; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

9.  Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux.

Authors:  Angela Pirillo; Patrizia Uboldi; Gianluca Pappalardo; Hartmut Kuhn; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787

10.  Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression.

Authors:  Natividad Ruiz-Velasco; Angeles Domínguez; Miguel A Vega
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

View more
  9 in total

1.  A biochemical fluorometric method for assessing the oxidative properties of HDL.

Authors:  Theodoros Kelesidis; Judith S Currier; Diana Huynh; David Meriwether; Christina Charles-Schoeman; Srinivasa T Reddy; Alan M Fogelman; Mohamad Navab; Otto O Yang
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

Review 2.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

3.  Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-α, MMP-9, and MMP-2.

Authors:  V S Soumyarani; N Jayakumari
Journal:  Mol Cell Biochem       Date:  2012-04-17       Impact factor: 3.396

4.  High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways.

Authors:  Jianfeng Xu; Juying Qian; Xinxing Xie; Li Lin; Jianying Ma; Zheyong Huang; Mingqiang Fu; Yunzeng Zou; Junbo Ge
Journal:  Mol Cell Biochem       Date:  2012-08-14       Impact factor: 3.396

5.  Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein.

Authors:  Hyun-Joo Kim; Gil Sun Cha; Hyung-Joon Kim; Eun-Young Kwon; Ju-Youn Lee; Jeomil Choi; Ji-Young Joo
Journal:  J Periodontal Implant Sci       Date:  2018-02-27       Impact factor: 2.614

Review 6.  CD36 tango in cancer: signaling pathways and functions.

Authors:  Jingchun Wang; Yongsheng Li
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

7.  Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths.

Authors:  PinYu Cui; Yuan Chen; Nuremaguli Waili; YaXing Li; CuiLing Ma; Ying Li
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

8.  Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.

Authors:  Jiexia Wen; Yumei Chang; Shanshan Huo; Wenyan Li; Heling Huang; Yunhuan Gao; Hongyu Lin; Jianlou Zhang; Yonghong Zhang; Yuzhu Zuo; Xuebin Cao; Fei Zhong
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

Review 9.  Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.

Authors:  Martina B Lorey; Katariina Öörni; Petri T Kovanen
Journal:  Front Cardiovasc Med       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.